中国原研新药获批治疗复发转移性晚期乳腺癌，等

doi:10.3971/j.issn.1000-8578.2021.04.0001

中国原研新药获批治疗复发转移性晚期乳腺癌，等[J]. 肿瘤防治研究, 2021, 48(4): 439-440. DOI: 10.3971/j.issn.1000-8578.2021.04.0001

引用本文:

中国原研新药获批治疗复发转移性晚期乳腺癌，等[J]. 肿瘤防治研究, 2021, 48(4): 439-440. DOI: 10.3971/j.issn.1000-8578.2021.04.0001

Chinese Original Ground Medicine is Approved for Recurrent Metastatic Advanced Breast Cancer, etc[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 439-440. DOI: 10.3971/j.issn.1000-8578.2021.04.0001

Citation:

中国原研新药获批治疗复发转移性晚期乳腺癌，等

Chinese Original Ground Medicine is Approved for Recurrent Metastatic Advanced Breast Cancer, etc

摘要

HTML全文

参考文献(0)

施引文献

资源附件(0)

下载: 全尺寸图片幻灯片

返回文章

用微信扫码二维码

分享至好友和朋友圈